OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
The tumour-necrosis-factor-family molecule osteoprotegerin ligand (OPGL; also known as TRANCE, RANKL and ODF) has been identified as a potential osteoclast differentiation factor and regulator of interactions between T cells and dendritic cells in vitro. Mice with a disrupted opgl gene show severe osteopetrosis and a defect in tooth eruption, and completely lack osteoclasts as a result of an inability of osteoblasts to support osteoclastogenesis. Although dendritic cells appear normal, opgl-deficient mice exhibit defects in early differentiation of T and B lymphocytes. Surprisingly, opgl-deficient mice lack all lymph nodes but have normal splenic structure and Peyer's patches. Thus OPGL is a new regulator of lymph-node organogenesis and lymphocyte development and is an essential osteoclast differentiation factor in vivo.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Bone resorption is dependent on a cytokine known as RANKL (receptor activator of nuclear factor B ligand), a TNF family member that is essential for osteoclast formation, activity, and survival in normal and pathological states of bone remodeling.”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [64]
In the citing paper
“In the absence of RANK or RANKL, osteoclasts cannot form, function, or survive (62-64, 110, 111).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [64]
In the citing paper
“RANK and RANKL knockout mice were virtual phenocopies of each other (62)(63)(64), which indicated that RANK and RANKL had few if any roles beyond their mutual interactions.”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [64]
In the citing paper
“Another unexpected phenotype found in RANK and RANKL knockout mice was the total lack of lymph nodes (62,64).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [64]
In the citing paper
“Examination of mice genetically deficient in RANKL, RANK, or OPG also revealed no overt dendritic cell defects (62,64,170).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [64]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Self-citationOsteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
Self-citationYasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,228
Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu, S., & Steinman, R. M. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.6.1693 · Cited by 3,738
A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.
Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D., & Galibert, L. (1997) · Nature · doi:10.1038/36593 · Cited by 2,290
Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice
Soriano, P., Montgomery, C., Geske, R., & Bradley, A. (1991) · Cell · doi:10.1016/0092-8674(91)90499-o · Cited by 2,016
Yoshida, H., Hayashi, S.-I., Kunisada, T., Ogawa, M., Nishikawa, S., Okamura, H., Sudo, T., Shultz, L. D., & Nishikawa, S.-I. (1990) · Nature · doi:10.1038/345442a0 · Cited by 1,789
Self-citationManolagas, S. C., & Jilka, R. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502023320506 · Cited by 1,668
Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice.
Peschon, J. J., Morrissey, P. J., Grabstein, K. H., Ramsdell, F. J., Maraskovsky, E., Gliniak, B. C., Park, L. S., Ziegler, S. F., Williams, D. E., Ware, C. B., et al. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.5.1955 · Cited by 1,555
c-Fos: a Key Regulator of Osteoclast-Macrophage Lineage Determination and Bone Remodeling
Grigoriadis, A. E., Wang, Z.-Q., Cecchini, M. G., Hofstetter, W., Felix, R., Fleisch, H. A., & Wagner, E. F. (1994) · Science · doi:10.1126/science.7939685 · Cited by 1,260
Cited by
Items 801–900 of 1,030
van de Loo, F. A. J., Bennink, M. B., Arntz, O. J., Smeets, R. L., Lubberts, E., Joosten, L. A. B., van Lent, P. L. E. M., Roo, C. J. J. C., Cuzzocrea, S., Segal, B. H., et al. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63509-2 · Cited by 104
“Furthermore, we found increased osteoprotegerin ligand (OPGL/RANKL) expression in the inflamed synovium of p47phox / mice, a key mediator in osteoclast differentiation.(55,56) The NADPH oxidase complex, including the p47phox protein, is present in the ruffled border of osteoclasts actively resorbing bone.”
BackgroundArthritogenic alphaviruses: new insights into arthritis and bone pathology
Chen, W., Foo, S., Sims, N. A., Herrero, L. J., Walsh, N. C., & Mahalingam, S. (2014) · Trends in Microbiology · doi:10.1016/j.tim.2014.09.005 · Cited by 106
Quinn, J. M. W., Sims, N. A., Saleh, H., Mirosa, D., Thompson, K., Bouralexis, S., Walker, E. C., Martin, T. J., & Gillespie, M. T. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5720 · Cited by 94
Mahamed, D. A., Marleau, A., Alnaeeli, M., Singh, B., Zhang, X., Penninger, J. M., & Teng, Y.-T. A. (2005) · Diabetes · doi:10.2337/diabetes.54.5.1477 · Cited by 95
Self-citationHayashi, T., Kaneda, T., Toyama, Y., Kumegawa, M., & Hakeda, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203836200 · Cited by 97
Michigami, T., Ihara-Watanabe, M., Yamazaki, M., & Ozono, K. (2001) · PubMed · Cited by 96
The origins and formation of bone-resorbing osteoclasts
Elson, A., Anuj, A., Barnea-Zohar, M., & Reuven, N. (2022) · Bone · doi:10.1016/j.bone.2022.116538 · Cited by 95
Mori, K., Le Goff, B., Charrier, C., Battaglia, S., Heymann, D., & Rédini, F. (2007) · Bone · doi:10.1016/j.bone.2006.11.006 · Cited by 95
“RANK expressed on osteoclasts/osteoclast precursors has been largely described as a key receptor that control osteoclast differentiation, activity and survival [12,14,15,20].”
BackgroundInfluentialNuclear Receptors in Bone Physiology and Diseases
Imai, Y., Youn, M.-Y., Inoue, K., Takada, I., Kouzmenko, A., & Kato, S. (2013) · Physiological Reviews · doi:10.1152/physrev.00008.2012 · Cited by 88
Kinetics of RANKL, RANK and OPG expressions in experimentally induced rat periapical lesions
Kawashima, N., Suzuki, N., Yang, G., Ohi, C., Okuhara, S., Nakano-Kawanishi, H., & Suda, H. (2007) · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · doi:10.1016/j.tripleo.2006.11.036 · Cited by 95
Osteoprotegerin and RANKL differentially regulate angiogenesis and endothelial cell function
McGonigle, J. S., Giachelli, C. M., & Scatena, M. (2008) · Angiogenesis · doi:10.1007/s10456-008-9127-z · Cited by 100
“The physiological relevance of the OPG/RANKL/RANK system is underscored by the severe osteoporosis observed in OPGdeficient mice and by the osteopetrotic phenotype of RANKL- and RANK-deficient mice [9, 16–19].”
BackgroundArai, A., Mizoguchi, T., Harada, S., Kobayashi, Y., Nakamichi, Y., Yasuda, H., Penninger, J. M., Yamada, K., Udagawa, N., & Takahashi, N. (2012) · Journal of Cell Science · doi:10.1242/jcs.099986 · Cited by 104
“Osteoblasts express two cytokines, colony-stimulating factor 1 (CSF-1, also called macrophage colony-stimulating factor) and receptor activator of NF-κB ligand (RANKL), both of which are essential to osteoclastic differentiation (Arron and Choi, 2000; Boyle et al., 2003; Hofbauer et al., 2000; Kong et al., 1999; Lacey…”
BackgroundMethodInfluentialSelf-citationRANKL and RANK: From Mammalian Physiology to Cancer Treatment
Rao, S., Cronin, S. J. F., Sigl, V., & Penninger, J. M. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.11.001 · Cited by 100
Self-citationTakami, M., Takahashi, N., Udagawa, N., Miyaura, C., Suda, K., Woo, J.-T., Martin, T. J., Nagai, K., & Suda, T. (2000) · Endocrinology · doi:10.1210/endo.141.12.7852 · Cited by 93
Osteocyte-directed bone demineralization along canaliculi
Nango, N., Kubota, S., Hasegawa, T., Yashiro, W., Momose, A., & Matsuo, K. (2016) · Bone · doi:10.1016/j.bone.2015.12.006 · Cited by 94
Zhou, X., Moussa, F. M., Mankoci, S., Ustriyana, P., Zhang, N., Abdelmagid, S. M., Molenda, J., Murphy, W. L., Safadi, F. F., & Sahai, N. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.05.007 · Cited by 96
“MCSF/RANKL induced the differentiation of mHSCs into osteoclasts[63], which were distinguished by their TRAP-positive and multinucleated phenotype (Fig.”
BackgroundBando, J. K., Gilfillan, S., Song, C., McDonald, K. G., Huang, S. C., Newberry, R. D., Kobayashi, Y., Allan, D., Carlyle, J. R., Cella, M., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.04.012 · Cited by 100
“RANK and RANKL Conditionally Deficient Mice Have Partial Defects in Secondary Lymphoid Tissue Organogenesis Unlike Tnfsf11 / and Tnfrsf11a / mice, which have impaired lymph node organogenesis (Dougall et al., 1999; Kim et al., 2000; Kong et al., 1999), Tnfsf11Rorc and Tnfrsf11a Rorc mice developed normal numbers of ce…”
BackgroundMethodInfluentialRANKL-RANK signaling regulates osteoblast differentiation and bone formation
Cao, X. (2018) · Bone Research · doi:10.1038/s41413-018-0040-9 · Cited by 94
Factor VIII-von Willebrand Factor Complex Inhibits Osteoclastogenesis and Controls Cell Survival
Baud’huin, M., Duplomb, L., Télétchéa, S., Charrier, C., Maillasson, M., Fouassier, M., & Heymann, D. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.030312 · Cited by 100
Hirbe, A. C., Uluçkan, Ö., Morgan, E. A., Eagleton, M. C., Prior, J. L., Piwnica-Worms, D. R., Trinkaus, K. M., Apicelli, A. J., & Weilbaecher, K. N. (2006) · Blood · doi:10.1182/blood-2006-09-048686 · Cited by 99
Osteoimmunology at the nexus of arthritis, osteoporosis, cancer, and infection
Jones, D., Glimcher, L. H., & Aliprantis, A. O. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46262 · Cited by 91
Effect of CD44 deficiency on in vitro and in vivo osteoclast formation
de Vries, T. J., Schoenmaker, T., Beertsen, W., van der Neut, R., & Everts, V. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20326 · Cited by 92
Dental Cells Express Factors That Regulate Bone Resorption
Rani, C. S. S., & MacDougall, M. J. (2000) · Molecular Cell Biology Research Communications · doi:10.1006/mcbr.2000.0205 · Cited by 108
Role for osteoprotegerin in rheumatoid inflammation
Saidenberg-Kermanac’h, N., Cohen-Solal, M. E., Bessis, N., de Vernejoul, M. C., & Boissier, M. (2004) · Joint Bone Spine · doi:10.1016/s1297-319x(03)00131-3 · Cited by 100
“[13] Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, Morony S, et al.”
BackgroundRomero, G., Sneddon, W. B., Yang, Y., Wheeler, D., Blair, H. C., & Friedman, P. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.102970 · Cited by 91
Calcium phosphate-based materials regulate osteoclast-mediated osseointegration
Wang, X., Yu, Y., Ji, L., Geng, Z., Wang, J., & Liu, C. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.05.003 · Cited by 93
Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumab
Anastasilakis, A. D., Toulis, K. A., Πολύζος, Σ., Anastasilakis, C. D., & Makras, P. (2012) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s24239 · Cited by 98
“…are expressed in cells of the immune system, including activated T lymphocytes, B cells, and dendritic cells, 41,42 and RANK activation by RANKL is also essential for the growth of T cells and function of dendritic cells, 3,43 and is considered to play a key role in the development of lymph nodes.”
The immune regulatory protein B7-H3 promotes osteoblast differentiation and bone mineralization
Suh, W.-K., Wang, S. X., Jheon, A. H., Moreno, L., Yoshinaga, S. K., Ganss, B., Sodek, J., Grynpas, M. D., & Mak, T. W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405259101 · Cited by 93
Self-citationDendritic Cells at the Osteo-Immune Interface: Implications for Inflammation-Induced Bone Loss
Alnaeeli, M., Park, J., Mahamed, D., Penninger, J. M., & Teng, Y.-T. A. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070314 · Cited by 93
“RANKL- and RANK-deficient mice have normal DC numbers and functions,((6,9)) indicating that RANK/RANKL signaling is not essential for DC development or function.”
BackgroundSelf-citationPrevention and treatment of osteoporosis in inflammatory bowel disease
Lichtenstein, G. R., Sands, B. E., & Pazianas, M. (2006) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200608000-00016 · Cited by 98
Current insights into the role of transforming growth factor-β in bone resorption
Fox, S. W., & Lovibond, A. C. (2005) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.09.008 · Cited by 93
Gannagé-Yared, M.-H., Yaghi, C., Habre, B., Khalife, S., Noun, R., Germanos-Haddad, M., & Trak-Smayra, V. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0797 · Cited by 93
Okahashi, N., Inaba, H., Nakagawa, I., Yamamura, T., Kuboniwa, M., Nakayama, K., Hamada, S., & Amano, A. (2004) · Infection and Immunity · doi:10.1128/iai.72.3.1706-1714.2004 · Cited by 103
“This molecule is essential for full osteoclastic differentiation from hematopoietic precursor cells into mature multinucleated bone-resorptive osteoclasts in the presence of macrophage colony-stimulating factor (23, 24, 49, 58).”
BackgroundHruska, K. A., Saab, G., Mathew, S., & Lund, R. (2007) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2007.00300.x · Cited by 108
“PTH enhances osteoclastogenesis and bone resorption through increased expression of RANKL and decreased expression of OPG in osteoblasts (79).”
BackgroundInfluentialCurcumin protects against ovariectomy‐induced bone loss and decreases osteoclastogenesis
Kim, W. K., Ke, K., Sul, O., Kim, H. J., Kim, S. H., Lee, M. H., Kim, H. J., Kim, S. Y., Chung, H., & Choi, H. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23242 · Cited by 92
“RANKL in the development of OC has been demonstrated by the finding that RANKL-deficient mice are severely osteopetrotic due to a defect in OC differentiation [Kong et al., 1999].”
BackgroundClohisy, J. C., Frazier, E., Hirayama, T., & Abu‐Amer, Y. (2003) · Journal of Orthopaedic Research · doi:10.1016/s0736-0266(02)00133-x · Cited by 93
Aïoub, M., Lézot, F., Molla, M., Castaneda, B., Robert, B., Goubin, G., Néfussi, J. R., & Berdal, A. (2007) · Bone · doi:10.1016/j.bone.2007.07.023 · Cited by 91
“proteins in the RANK pathway [reviewed in [38]], were affected in Msx2 −/− when compared to Msx2 +/+ bone samples.”
BackgroundOsteoimmunology: The correlation between osteoclasts and the Th17/Treg balance in osteoporosis
Huang, F., Wong, P., Li, J., Lv, Z., Xu, L., Zhu, G., He, M., & Luo, Y. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17399 · Cited by 91
Kunnumakkara, A. B., Nair, S. A., Ahn, K. S., Pandey, M. K., Yi, Z., Liu, M., & Aggarwal, B. B. (2007) · Blood · doi:10.1182/blood-2007-01-067256 · Cited by 91
Ha, H., Kwak, H. B., Lee, S. K., Na, D. S., Rudd, C. E., Lee, Z. H., & Kim, H.-H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212626200 · Cited by 92
RANK/RANKL/OPG role in distraction osteogenesis
Pérez‐Sayáns, M., Martín, J. M. S., Barros, F., Rey, J. M. G., & García, A. G. (2010) · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · doi:10.1016/j.tripleo.2009.10.042 · Cited by 104
Estrogen Regulation of Immune Cell Bone Interactions
Weitzmann, M. N., & Pacifici, R. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1346.030 · Cited by 97
Sung, B., Murakami, A., Oyajobi, B. O., & Aggarwal, B. B. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3249 · Cited by 91
RetractedRANKL blockade prevents and treats aggressive osteosarcomas
Chen, Y., Di Grappa, M. A., Molyneux, S. D., McKee, T. D., Waterhouse, P., Penninger, J. M., & Khokha, R. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aad0295 · Cited by 88
Self-citationBone cell communication factors and Semaphorins
Negishi-Koga, T., & Takayanagi, H. (2012) · BoneKEy Reports · doi:10.1038/bonekey.2012.183 · Cited by 90
Apoptosis-associated uncoupling of bone formation and resorption in osteomyelitis
Marriott, I. (2013) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2013.00101 · Cited by 94
Shedding of RANKL by Tumor-Associated MT1-MMP Activates Src-Dependent Prostate Cancer Cell Migration
Sabbota, A. L., Kim, H.-R. C., Zhe, X., Fridman, R. A., Bonfil, R. D., & Cher, M. L. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4416 · Cited by 94
Effects of RANKL-Targeted Therapy in Immunity and Cancer
Cheng, M. L., & Fong, L. H. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2013.00329 · Cited by 96
“RANKL and RANK KO mice do not demonstrate diminished DC or monocyte development, and the function of these cells remains intact, suggesting that the interaction may not be required for activation (7, 36).”
BackgroundUccioli, L., Sinistro, A., Almerighi, C., Ciaprini, C., Cavazza, A., Giurato, L., Ruotolo, V., Spasaro, F., Vainieri, E., Rocchi, G., et al. (2009) · Diabetes Care · doi:10.2337/dc09-1141 · Cited by 90
“Indeed, activated T-cells are able to produce RANKL and initiate the differentiation program that leads to the formation of mature osteoclasts (21).”
BackgroundChen, N., Huang, M.-W., & Hsieh, S.-L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.270 · Cited by 102
“Results obtained using TRANCE/OPGL knockout mice have shown that production of the cytokines IL-2, IFN-g, IL-4, IL-5, and IL-6 is significantly reduced in purified opgl2/2 T cells (6).”
BackgroundMethodInfluentialSakuma, Y., Tanaka, K., Suda, M., Komatsu, Y., Yasoda, A., Miura, M., Ozasa, A., Narumiya, S., Sugimoto, Y., Ichikawa, A., et al. (2000) · Infection and Immunity · doi:10.1128/iai.68.12.6819-6825.2000 · Cited by 101
“Their functional relevance is clearly shown by the finding that ODF KO mice develop osteopetrosis and OCIF KO mice develop severe osteoporosis (6, 19).”
BackgroundPathogenesis of bone erosions in rheumatoid arthritis
Goldring, S. R. (2002) · Current Opinion in Rheumatology · doi:10.1097/00002281-200207000-00013 · Cited by 89
The Molecular Mechanism of Vitamin E as a Bone-Protecting Agent: A Review on Current Evidence
Wong, S. K., Mohamad, N.-V., Ibrahim, N. ‘., Chin, K., Shuid, A. N., & Ima-Nirwana, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061453 · Cited by 93
“This is due to an absence of osteoclasts as a result of an inability of osteoblasts to support osteoclastogenesis [51,52].”
BackgroundSoluble RANKL is physiologically dispensable but accelerates tumour metastasis to bone
Asano, T., Okamoto, K., Nakai, Y., Tsutsumi, M., Muro, R., Suematsu, A., Hashimoto, K., Okamura, T., Ehata, S., Nitta, T., et al. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0104-1 · Cited by 92
Lee, H., Jeon, H., Song, E., Han, M., Park, S., Lee, S. I., Yun, H., Kim, J., Kim, J., Lee, Y., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21873 · Cited by 101
The role of the bone microenvironment in skeletal metastasis
Zheng, Y., Zhou, H., Dunstan, C., Sutherland, R., & Seibel, M. (2012) · Journal of Bone Oncology · doi:10.1016/j.jbo.2012.11.002 · Cited by 79
Self-citationTunyogi-Csapó, M., Kis‐Tóth, K., Radács, M., Farkas, B., Jacobs, J. J., Finnegan, A., Mikecz, K., & Glant, T. T. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23653 · Cited by 94
“Although T cells in RA joints express RANKL (1,2), and these RANKL-positive T cells may come in contact with osteoclast precursors (3), their direct in vivo osteoclastogenic potential is probably limited.”
BackgroundYamashita, M., Otsuka, F., Mukai, T., Yamanaka, R., Otani, H., Matsumoto, Y., Nakamura, E., Takano, M., Sada, K., & Makino, H. (2010) · Regulatory Peptides · doi:10.1016/j.regpep.2010.03.003 · Cited by 92
“RANKL activates mature osteoclasts in vitro and leads rapidly to resorption of bone in vivo by activating preexisting osteoclasts [7,8].”
BackgroundCLONING AND CHARACTERIZATION OF OSTEOCLAST PRECURSORS FROM THE RAW264.7 CELL LINE
Cuetara, B., Crotti, T. N., O’Donoghue, A. J., & McHugh, K. P. (2006) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1290/0510075.1 · Cited by 89
Bone Cancer Pain: From Mechanism to Model to Therapy
Honoré, P., & Mantyh, P. W. (2000) · Pain Medicine · doi:10.1046/j.1526-4637.2000.00047.x · Cited by 98
Hou, J., Xue, Y., & Lin, Q.-M. (2012) · Acta Pharmacologica Sinica · doi:10.1038/aps.2012.83 · Cited by 90
The malignant clone and the bone-marrow environment
Podar, K., Richardson, P. G. G., Hideshima, T., Chauhan, D., & Anderson, K. C. (2007) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2007.08.002 · Cited by 98
Inhibition of p38 Mitogen-Activated Protein Kinase Prevents Inflammatory Bone Destruction
Mbalaviele, G., Anderson, G. D., Jones, A., Ciechi, P. D., Settle, S., Mnich, S., Thiede, M. A., Abu‐Amer, Y., Portanova, J. P., & Monahan, J. B. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.100362 · Cited by 97
The roles of immune cells in bone healing; what we know, do not know and future perspectives
El-Jawhari, J. J., Jones, E., & Giannoudis, P. V. (2016) · Injury · doi:10.1016/j.injury.2016.10.008 · Cited by 86
“In contrast, RANKL and M-CSF secreted by osteoblasts can improve the survival and the function of osteoclasts [93,94].”
BackgroundKatagiri, M., Hakeda, Y., Chikazu, D., Ogasawara, T., Takato, T., Kumegawa, M., Nakamura, K., & Kawaguchi, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007393200 · Cited by 95
RANKL and RANK as novel therapeutic targets for arthritis
Nakashima, T., & Penninger, J. M. (2003) · Current Opinion in Rheumatology · doi:10.1097/00002281-200305000-00016 · Cited by 92
Self-citationA Novel Interaction between Thyroid Hormones and 1,25(OH)2D3 in Osteoclast Formation
Miura, M., Tanaka, K., Komatsu, Y., Suda, M., Yasoda, A., Sakuma, Y., Ozasa, A., & Nakao, K. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6561 · Cited by 88
Ahern, E., Harjunpää, H., Barkauskas, D., Allen, S., Takeda, K., Yagita, H., Wyld, D., Dougall, W. C., Teng, M. W. L., & Smyth, M. J. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0606 · Cited by 87
“RANK (TNFRSF11a) and RANKL (TNFSF11) are currently best known in clinical practice for their role in bone homeostasis, as the differentiation of osteoclasts from the monocyte–macrophage lineage requires RANKL interaction with RANK expressed on the myeloid osteoclast precursors (8, 9).”
BackgroundLi, B., Wang, P., Jiao, J., Wei, H., Xu, W., & Zhou, P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.824117 · Cited by 98
A role for γ/δ T cells in a mouse model of fracture healing
Colburn, N. T., Zaal, K. J. M., Wang, F., & Tuan, R. S. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24520 · Cited by 88
The role of T helper type 17 cells in inflammatory arthritis
Sarkar, S., Cooney, L. A., & Fox, D. A. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2009.04016.x · Cited by 94
Auger, G. A., Pease, J. E., Shen, X., Xanthou, G., & Barker, M. D. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200204)32:4<1003::aid-immu1003>3.0.co;2-p · Cited by 39
Osteoclasts and the immune system
Nakashima, T., & Takayanagi, H. (2009) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-009-0089-z · Cited by 94
“Intriguingly, in addition to a defect in osteoclasts, RANKLdeficient mice have a defect in the development and organization of secondary lymphoid tissue [17].”
BackgroundInfluence of bisphosphonates on orthodontic tooth movement in mice
Fujimura, Y., Kitaura, H., Yoshimatsu, M., Eguchi, T., Kohara, H., Morita, Y., & Yoshida, N. (2009) · European Journal of Orthodontics · doi:10.1093/ejo/cjp068 · Cited by 97
Komarova, S. V., Pilkington, M. F., Weidema, A. F., Dixon, S. J., & Sims, S. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m206421200 · Cited by 87
Osteoclast Differentiation Is Impaired in the Absence of Inhibitor of κB Kinase α
Chaisson, M. L., Branstetter, D. G., Derry, J. M. J., Armstrong, A. P., Tometsko, M. E., Takeda, K., Akira, S., & Dougall, W. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406392200 · Cited by 96
Role of the RANK/RANKL Pathway in Multiple Myeloma
Raje, N. S., Bhatta, S. S., & Terpos, E. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1537 · Cited by 94
“This pathway is critical for the differentiation, activation, and survival of osteoclasts; accordingly, RANK or RANKL knockout mice have osteopetrosis and severe skeletal abnormalities due to their inability to remodel bone (8, 9).”
BackgroundBuduneli, N., Buduneli, E., & Kütükçüler, N. (2009) · Journal of Periodontology · doi:10.1902/jop.2009.090106 · Cited by 86
Prostaglandin and the Suppression of Phagocyte Innate Immune Responses in Different Organs
de Medeiros, A. I., Peres‐Buzalaf, C., Verdan, F. F., & Serezani, C. H. (2012) · Mediators of Inflammation · doi:10.1155/2012/327568 · Cited by 101
“…and activation of osteoclasts are tightly regulated by osteoblasts through the release of receptor activator of NF-κ B ligand (RANKL) and macrophage colony-stimulating factor (M-CSF) [61], which are required for the di ff erentiation of osteoclast progenitors into mature osteo-clasts [62].”
Hsu, Y.-H., Chen, W.-Y., Chan, C.-H., Wu, C.-H., Sun, Z.-J., & Chang, M.-S. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20102234 · Cited by 88
Cho, S. W., Sun, H. J., Yang, J., Jung, J. Y., An, J. H., Cho, H. Y., Choi, H. J., Kim, S. W., Kim, S. Y., Kim, D., et al. (2009) · Molecular Therapy · doi:10.1038/mt.2009.153 · Cited by 92
The role of CD45+CD4+CD3– cells in lymphoid organ development
Cupedo, T., Kraal, G., & Mebius, R. E. (2002) · Immunological Reviews · doi:10.1034/j.1600-065x.2002.18905.x · Cited by 87
Differentiation of human bone‐derived cells grown on GRGDSP‐peptide bound titanium surfaces
Zreiqat, H., Akin, F. A., Howlett, C. R., Markovic, B., Haynes, D. R., Lateef, S. R., & Hanley, L. (2002) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.10376 · Cited by 92
Mukohyama, H., Ransjö, M., Taniguchi, H., Ohyama, T., & Lerner, U. H. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2599 · Cited by 89
Opg, Rank, and Rankl in Tooth Development: Co-ordination of Odontogenesis and Osteogenesis
Ohazama, A., Courtney, J., & Sharpe, P. T. (2004) · Journal of Dental Research · doi:10.1177/154405910408300311 · Cited by 111
Lai, F. P. L., Cole‐Sinclair, M., Cheng, W. ‐., Quinn, J. M. W., Gillespie, M. T., Sentry, J. W., & Schneider, H. ‐. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05018.x · Cited by 86
“…stimulation Receptor activator of nuclear factor jB ligand (RANKL) is member 11 of the tumour necrosis factor superfamily (TNFSF11) of cytokines, and plays a central role in development and function of osteoclasts, lymphoid tissue and mammary epithelium (Kong et al, 1999, 2000; Fata et al, 2000).”
BackgroundPike, J. W., & Meyer, M. B. (2012) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2012.03.004 · Cited by 86
From bone biology to clinical outcome: state of the art and future perspectives
Schett, G. A., Saag, K. G., & Bijlsma, J. W. J. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.135061 · Cited by 86
“Moreover, T cells can act as a source of RANKL themselves and thus, in principle, can support osteoclastogenesis.”
BackgroundExtraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications
Body, J. J., Bergmann, P., Boonen, S., Devogelaer, J.-P., Gielen, E., Goemaere, S., Kaufman, J., Rozenberg, S., & Reginster, J.-Y. (2012) · Osteoporosis International · doi:10.1007/s00198-011-1891-8 · Cited by 96
“However, though RANK and RANK-L are essential in mice for ontogeny of the lymphoid tissues [227], patients with a mutation of the RANKL gene did not present immunological defects [230].”
BackgroundMountzios, G., Dimopoulos, M. A., Bamias, A., Papadopoulos, G., Kastritis, E., Syrigos, K., Pavlakis, G., & Terpos, E. (2006) · Acta Oncologica · doi:10.1080/02841860600635870 · Cited by 94
“Preclinical data have documented that transgenic mice that over-express OPG develop severe osteopetrosis [17] and targeted deletion of OPG leads to severe osteoporosis [18].”
BackgroundIchikawa, H., & Aggarwal, B. B. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1749 · Cited by 90
Strength of TRAF6 signalling determines osteoclastogenesis
Kadono, Y., Okada, F., Perchonock, C. E., Jang, H. D., Lee, S. Y., Kim, N., & Choi, Y. (2005) · EMBO Reports · doi:10.1038/sj.embor.7400345 · Cited by 92
Osteoprotegerin and Osteoclast Differentiation Factor in Tooth Eruption
Wise, G. E., Lumpkin, S. J., Huang, H., & Zhang, Q. (2000) · Journal of Dental Research · doi:10.1177/00220345000790120301 · Cited by 94
Molecular control of bone remodeling and osteoporosis
Kong, Y., & Penninger, J. M. (2000) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00178-9 · Cited by 100
Self-citationYamamoto, A., Miyazaki, T., Kadono, Y., Takayanagi, H., Miura, T., Nishina, H., Katada, T., Wakabayashi, K., Oda, H., Nakamura, K., et al. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.4.612 · Cited by 85
“Mice deficient in RANKL showed osteopetrotic pathology caused by the lack of osteoclast differentiation((7)) and targeted disruption of RANK, the receptor of RANKL, also induced osteopetrosis in mice.”
BackgroundDenosumab: A comprehensive review
Narayanan, P. (2013) · South Asian Journal of Cancer · doi:10.4103/2278-330x.119895 · Cited by 97
Recent Advances in Osteoclast Biological Behavior
Sun, Y., Li, J., Xie, X., Gu, F., Sui, Z., Zhang, K., & Yu, T. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.788680 · Cited by 90
“Loss of RANKL in mice results in severe osteopetrosis, while overexpression of soluble RANKL leads to severe osteoporosis (Kong et al., 1999; Mizuno et al., 2002).”
BackgroundBone Disease in Multiple Myeloma: Biologic and Clinical Implications
Bernstein, Z. S., Kim, E. B., & Raje, N. S. (2022) · Cells · doi:10.3390/cells11152308 · Cited by 97
“Of note, it was found that rats devoid of RANK and RANKL genes had no OCs [45,46].”
BackgroundDarnay, B. G., Besse, A., Poblenz, A. T., Lamothe, B., & Jacoby, J. J. (2007) · Springer eBooks · doi:10.1007/978-0-387-70630-6_12 · Cited by 93
Are Osteoclasts Needed for the Bone Anabolic Response to Parathyroid Hormone?
Pierroz, D. D., Bonnet, N., Baldock, P. A., Ominsky, M. S., Stolina, M., Kostenuik, P. J., & Ferrari, S. L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.101964 · Cited by 85
Metadata
- Authors
- Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., Khoo, W., Wakeham, A., Dunstan, C. R., Lacey, D. L., Mak, T. W., Boyle, W. J., & Penninger, J. M.
- Affiliations
- University of Toronto (CA)
- Amgen (United States) (US)
- Corresponding author
- Penninger, Josef M.
- Venue
- Nature
- Published
- 1999-01
- Volume
- 397
- Issue
- 6717
- Pages
- 315-323
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1534645474
- Cited by
- 3,351
- References
- 52
- Citations by year
- 2026: 27 · 2025: 47 · 2024: 58 · 2023: 71 · 2022: 88 · 2021: 114 · 2020: 121 · 2019: 102 · 2018: 95 · 2017: 115 · 2016: 107 · 2015: 125 · 2014: 119 · 2013: 138 · 2012: 162
- FWCI
- 49.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- osteoprotegerin ligand, RANKL, osteoclastogenesis, osteopetrosis, tooth eruption, lymphocyte development, dendritic cells, T cell development, B cell development, osteoblasts
- MeSH terms
- Animals, B-Lymphocytes, Carrier Proteins, Cell Differentiation, Cells, Cultured, Dendritic Cells, Female, Embryonic and Fetal Development, Growth Substances, Hematopoiesis, Extramedullary, Hematopoietic Stem Cells, Lymph Nodes, Lymphocyte Activation, Lymphocytes, Male, Membrane Glycoproteins, Mice, Inbred BALB C, Mice, Inbred C57BL, Molecular Sequence Data, Osteoclasts, Osteogenesis, Osteopetrosis, T-Lymphocytes, Thymus Gland, Cytokines, Mutagenesis, Bone Remodeling, Gene Targeting, Leukopoiesis, Mice, RANK Ligand, Receptor Activator of Nuclear Factor-kappa B
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.